Literature DB >> 20866111

Codon 129 polymorphism specific cerebrospinal fluid proteome pattern in sporadic Creutzfeldt-Jakob disease and the implication of glycolytic enzymes in prion-induced pathology.

Joanna Gawinecka1, Jana Dieks, Abdul R Asif, Julie Carimalo, Uta Heinemann, Jan-Hendrik Streich, Hassan Dihazi, Walter Schulz-Schaeffer, Inga Zerr.   

Abstract

Cerebrospinal fluid (CSF) contains a dynamic and complex mixture of proteins, which can reflect a physiological and pathological state of the central nervous system. In our present study, we show CSF protein patterns from patients with the two most frequent subtypes of sporadic Creutzfeldt-Jakob disease (sCJD) defined by the codon 129 genotype (MM, MV, and VV) and the protease-resistant form of prion protein (type 1 and type 2). The densitometric analysis of 2D gels showed up-regulation of 27 and down-regulation of 3 proteins in the MM-sCJD as well as the up-regulation of 24 proteins in the VV-sCJD as compared to nondemented control. Almost 40% of sCJD specific regulated proteins in CSF are involved in glucose metabolism, regardless of the codon 129 polymorphism. The increase in CSF levels of lactate dehydrogenase (LDH), glucose-6-phosphate isomerase (G6PI), and fructose-bisphosphate aldolase A (ALDOA) were validated on a larger group of sCJD patients including three possible codon 129 polymorphism carriers and three control groups consisting of nondemented, neurological cases as well as patients suffering from Alzheimer's disease or vascular dementia. Subsequently, the abundance of these glycolytic enzymes in the brain as well as their cellular localization were determined. This study demonstrates for the first time the implication of G6PI in prion-induced pathology as well as its cellular translocalization in sCJD. The identification of sCJD-regulated proteins in CSF of living symptomatic patients in our study can broaden our knowledge about pathological processes occurring in sCJD, as they are still not fully understood.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20866111     DOI: 10.1021/pr1004604

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  9 in total

1.  Global protein differential expression profiling of cerebrospinal fluid samples pooled from Chinese sporadic CJD and non-CJD patients.

Authors:  Cao Chen; Di Xiao; Wei Zhou; Qi Shi; Hui-Fang Zhang; Jin Zhang; Chan Tian; Jian-Zhong Zhang; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2013-08-04       Impact factor: 5.590

2.  Longitudinal study of differential protein expression in an Alzheimer's mouse model lacking inducible nitric oxide synthase.

Authors:  Michael D Hoos; Brenna M Richardson; Matthew W Foster; Angela Everhart; J Will Thompson; M Arthur Moseley; Carol A Colton
Journal:  J Proteome Res       Date:  2013-09-18       Impact factor: 4.466

3.  Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt-Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress.

Authors:  Waqas Tahir; Saima Zafar; Franc Llorens; Amandeep Singh Arora; Katrin Thüne; Matthias Schmitz; Nadine Gotzmann; Niels Kruse; Brit Mollenhauer; Juan Maria Torres; Olivier Andréoletti; Isidre Ferrer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

4.  Anchorless 23-230 PrPC interactomics for elucidation of PrPC protective role.

Authors:  Saima Zafar; Abdul R Asif; Sanja Ramljak; Waqas Tahir; Matthias Schmitz; Inga Zerr
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

5.  Proteomics analysis of amyloid and nonamyloid prion disease phenotypes reveals both common and divergent mechanisms of neuropathogenesis.

Authors:  Roger A Moore; Dan E Sturdevant; Bruce Chesebro; Suzette A Priola
Journal:  J Proteome Res       Date:  2014-08-29       Impact factor: 4.466

6.  Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients.

Authors:  Matthias Schmitz; Franc Llorens; Alexander Pracht; Tobias Thom; Ângela Correia; Saima Zafar; Isidre Ferrer; Inga Zerr
Journal:  Aging (Albany NY)       Date:  2016-11-14       Impact factor: 5.682

7.  Altered mRNA and Protein Expression of Monocarboxylate Transporter MCT1 in the Cerebral Cortex and Cerebellum of Prion Protein Knockout Mice.

Authors:  Sanja Ramljak; Matthias Schmitz; Cendrine Repond; Inga Zerr; Luc Pellerin
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

8.  Expression of genes involved in the T cell signalling pathway in circulating immune cells of cattle 24 months following oral challenge with Bovine Amyloidotic Spongiform Encephalopathy (BASE).

Authors:  Andrea Trovato; Simona Panelli; Francesco Strozzi; Caterina Cambulli; Ilaria Barbieri; Nicola Martinelli; Guerino Lombardi; Rossana Capoferri; John L Williams
Journal:  BMC Vet Res       Date:  2015-05-09       Impact factor: 2.741

9.  Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients.

Authors:  Inga Zerr; Anna Villar-Piqué; Vanda Edit Schmitz; Anna Poleggi; Maurizio Pocchiari; Raquel Sánchez-Valle; Miguel Calero; Olga Calero; Inês Baldeiras; Isabel Santana; Gabor G Kovacs; Franc Llorens; Matthias Schmitz
Journal:  Biomolecules       Date:  2019-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.